Učitavanje...

Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.

Anastrozole is the first aromatase inhibitor to show a significant survival advantage over megestrol acetate in post-menopausal women with advanced breast cancer. The rationale for extending the use of aromatase inhibitors to the treatment of early breast cancer is based on the efficacy observed in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Lønning, P. E.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group|1 1998
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2062757/
https://ncbi.nlm.nih.gov/pubmed/9741783
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!